Tu1730 LONG-TERM EFFICACY AND SAFETY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: 104-WEEK RESULTS FROM THE FORTIFY STUDY
Gastroenterology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Gastroenterology(2023)